The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
 
Sik-Kwan Chan
No Relationships to Disclose
 
Cheng Lin
No Relationships to Disclose
 
Shao Hui Huang
No Relationships to Disclose
 
Tin Ching Chau
No Relationships to Disclose
 
Qiaojuan Guo
No Relationships to Disclose
 
Brian O'Sullivan
Consulting or Advisory Role - IBA; Merck; Merck; Merck; Merck; Pfizer
 
Ka-On Lam
Honoraria - Amgen; Amgen; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Linton Pharma; Merck; MSD; MSD; Novartis; Sanofi/Aventis; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; MSD; Novartis
Research Funding - Bayer; Roche; Taiho Pharmaceutical (Inst)
 
Sze Chun Chau
No Relationships to Disclose
 
Ann SY Chan
No Relationships to Disclose
 
Chi-Chung Tong
No Relationships to Disclose
 
Varut Vardhanabhuti
No Relationships to Disclose
 
Dora LW Kwong
No Relationships to Disclose
 
Tsz Him So
No Relationships to Disclose
 
Sherry CY Ng
No Relationships to Disclose
 
To Wai Leung
No Relationships to Disclose
 
Mai-Yee Luk
No Relationships to Disclose
 
Anne WM Lee
No Relationships to Disclose
 
Cheuk-Wai Choi
No Relationships to Disclose
 
Jianji Pan
No Relationships to Disclose
 
Victor Ho-Fun Lee
Honoraria - Amgen; AstraZeneca; Lilly; Merck Sharp & Dohme; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Merck Sharp & Dohme; Pfizer
Research Funding - AstraZeneca; Pfizer
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Pfizer; Roche